Skip to content

The Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment and Gut Microbiota in Patients after Stroke

The Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Cognitive Impairment and Gut Microbiota in Patients after Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111142
Enrollment
Unknown
Registered
2025-10-27
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

control group:common rehabilitation+pseudo-stimulation
observation group:common rehabilitation+high-frequency repetitive transcranial magnetic stimulation

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. meets the diagnostic criteria for stroke and is confirmed by cranial CT or MRI imaging; 2. presence of cognitive impairment (Montreal Cognitive Assessment, MoCA<26); 3. first stroke with stroke duration between 1 and 6 months; 4. 30 years <= age <= 75 years; 5. no severe aphasia and able to complete cognitive tests; 6. overall stabilisation of the condition, with clear mental status and stable vital signs; 7. Normal pre-stroke cognitive function; 8. The person himself/herself or legal guardian agrees and has signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Non first stroke; 2.CT/MRI confirmed complete damage to the left prefrontal cortex; 3.Transcranial surgery or skull defect; 4.Metal or pacemaker implants; 5.History of brain tumors, history of brain trauma, history of seizures, and risk of seizures; 6.Cognitive decline before stroke; 7.The Hamilton Depression Scale (HAMD) score is greater than 17 points; 8.Any neurological and psychiatric comorbidities and emotional disorders that may affect the results; 9.Medications such as antibiotics and probiotics that have been proven to have an impact on the gut microbiota and its metabolite structure; 10.Any other factors that may affect cognitive assessment and treatment;

Design outcomes

Primary

MeasureTime frame
cognitive function;

Secondary

MeasureTime frame
daily living ability;gut microbiota;

Countries

China

Contacts

Public ContactJie Gao

Affiliated Hospital of Nantong University

gaojie230@163.com+86 513 81168121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026